September 10, 2020

ProSciento Closes Growth Financing from 1315 Capital Read More »

September 1, 2020

ProSciento Appoints Stephen Mullennix as Chief Financial Officer Read More »

ProSciento - Top Work Places


View Recent Webinar


August 21, 2020

Customized Programs for Clinical Development and Global Regulatory Services Read More »

July 8, 2020

184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers Read More »

December 14, 2019

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: